
Theme 1
Synthetic Biology for Natural Products
We engineer Streptomyces bacteria to discover and make new bioactive molecules, from single enzymes to complete pathways.
Research theme 2
We build high-yielding cell-free systems from diverse bacteria to make peptides, proteins and small molecules, and to prototype pathways quickly.
A cell-free system is a cell extract that carries out gene expression in a test tube. It holds the ribosomes, enzymes and metabolism of a living cell, but contains no living cell. That makes it fast, open to measurement and easy to automate.
We develop high-yielding extracts for academic and industrial use, and our best systems reach up to 4 mg/mL of peptide or protein. Our toolkit spans model organisms such as E. coli and non-model species including Streptomyces venezuelae and Klebsiella pneumoniae.
Liquid-handling robots let us test hundreds of conditions in one plate. We use cell-free reactions to screen genetic parts, build biosensors and prototype biosynthetic pathways without the constraints of living cells.
We co-organise the London Cell-free Biological Products Network. It meets twice a year at Imperial and UCL and brings together 30 to 50 researchers from academia and industry.
Key innovation: we are developing high-yielding, affordable cell-free systems for engineering peptides, proteins and small molecules through cell-free biosynthesis.
How cell-free works
A cell-free system uses the machinery of a cell without the cell. First we make the extract, then we use it to make protein.

We grow bacteria such as E. coli or Streptomyces venezuelae and harvest them at the growth phase that gives the most active extract.

We collect the cells by centrifugation. The pellet is the starting material for the extract.

We wash the pellet and keep the tube cold, ready for lysis.

We break open the cells, add a heat incubation step where the protocol needs one, and spin down the debris. The clear extract holds the ribosomes, enzymes and other machinery that a living cell uses to make protein.

We add the DNA that encodes our protein or pathway, with the energy sources, amino acids and salts that fuel the reaction.


The extract transcribes the DNA and translates the messenger RNA. When the gene encodes the fluorescent protein mScarlet-I, the reaction turns pink (right: our E. coli cell-free reactions).

SDS-PAGE is used to analsye overproduced proteins. Reactions that make a protein show an enlarged band when compared to the control.


We read fluorescence or enzyme activity in a plate reader. Liquid-handling robots set up many conditions in parallel in 384-well plates.
Photographs and cartoons: Moore group. Gel: Nagappa et al., Front. Bioeng. Biotechnol. (2022) 10:992708 (opens in a new tab), CC BY.
Protein production
Cell-free reactions make enough protein to see, measure and purify. These data come from reactions in the Moore group.
Automation
Cell-free reactions can be automated using liquid-handling robots. We have published different automated approaches to assemble 384-well plates with 2-10 µL reactions and measured ribosome binding site variants and promoters from Bacillus megaterium (Moore et al., PNAS 2018), as well as antimicrobial resitance (Bergum et a., Synthetic Biology 2026).
We use a small Myra robotic system in preference to manual pipetting for preparing 384 plate reactions. We compared human versus robot and found no statistical difference. We used the workflow to show that antibiotic resistance genes change the potency of antibiotics, which links this theme to our antimicrobial resistance work (Bergum et a., Synthetic Biology 2026).
Read the papers: Bergum et al., Synthetic Biology (2026) 11:ysag010 (opens in a new tab), and the Methods in Enzymology chapter (2026, doi:10.1016/bs.mie.2026.09.046 (opens in a new tab)).
Each entry links to the paper, its Altmetric record and a live citation count.
Synth. Biol. (2026) 11:ysag010

Chemical Society Reviews (2025) 54:4314-4352

Front. Bioeng. Biotechnol. (2022)10:992708

Engineering Biology 6(2):62-68 (2022)

ACS Synth. Biol. (2021) 10: 402-411

Proceedings of the National Academy of Sciences, USA (2018) 115:E4340-E4349

Nat. Prod. Rep. (2023) 40:228-236
Frontiers in Bioengineering and Biotechnology 9:799122 (2021)
JoVE (2021) 10.3791/63012
Synth. Biol. (2021) 6:ysab021
Emerging Topics in Biosciences (2019) 3: 529-535
Biochemical Society Transactions (2017) 45:785-791
Biotechnol J (2017) 12:1600678
Methods in Enzymology (2026) DOI: 10.1016/bs.mie.2026.09.046

Theme 1
We engineer Streptomyces bacteria to discover and make new bioactive molecules, from single enzymes to complete pathways.

Theme 3
We use cell-free systems to measure how antibiotics work and how bacteria resist them, and to test alternative antimicrobials, with the UK Health Security Agency.
We welcome enquiries from prospective students and fellows, and from industry and public-sector partners.
Past and current funders
Leverhulme Trust (opens in a new tab)
BBSRC (opens in a new tab)
Royal Society (opens in a new tab)
Wellcome Trust (opens in a new tab)
FAPESP (opens in a new tab)
Biochemical Society (opens in a new tab)
Syngenta (opens in a new tab)
Sanofi (opens in a new tab)
UKRI (opens in a new tab)
Horizon Europe (opens in a new tab)